Home Procurement NewsBristol Myers to buy RayzeBio for about $4.1 billion

Bristol Myers to buy RayzeBio for about $4.1 billion

December 26, 2023•

Bristol Myers Squibb said on Tuesday it will acquire radiopharmaceutical firm RayzeBio for about $4.1 billion.

Was this article helpful?

YesNo

Last modified: December 26, 2023

Previous: Presidency defends Tinubu’s intervention in Ondo, Rivers political crisis

Next: Israel grants Intel $3.2 billion for new $25 billion chip plant, biggest ever company investment in country

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The articles and content featured on this platform are sourced from various contributors and do not necessarily reflect the views or positions of Accountability Lab Nigeria. We do not author or edit the published materials. If you have concerns about any content or would like to request its removal, please contact us at @Accountability Lab Nigeria.

Recent Posts

Recent Comments

No comments to show.

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships

Accountability Lab Nigeria

Copyright © 2021 - Accountability Lab Nigeria

↑

Close